Treatment of Mitral Stenosis with Mitral Annular Calcification in Elderly Patients

Clinical Scenario

Degenerative mitral stenosis associated with mitral annular calcification (MAC) is a distinct, age-dependent pathology that requires different treatment strategies from other forms of mitral stenosis. Affected patients are typically elderly and present with significant comorbidities, including disease of other valves.

Treatment Approach & Goals

Management centres on pharmacological therapy directed at two primary targets:

Improvement of symptoms by controlling volume overload and heart rate.

Several classes of agents are employed to reach these goals. The complete evidence-based regimen — agent selection, sequencing, and clinical decision points — is in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1093/eurheartj/ehaf194

Degenerative MS related to MAC is a distinct age-dependent pathology requiring different treatment strategies.

Patients presenting with MAC are elderly and have significant comorbidities, including disease of other valves.

Diuretics, beta-blockers, digoxin, non-dihydropyridine calcium channel blockers, and ivabradine can improve symptoms by controlling volume overload and heart rate.

View source ↗